Acute coronary syndrome in patients with oncological diseases-Reference-Cited by-同舟云学术

Acute coronary syndrome in patients with oncological diseases

Published:2024-01-18 Issue:35 Volume: Page:12-18
ISSN:2949-2807
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Bliznyuk S. А.¹^ORCID,Komarova A. G.¹^ORCID,Libov I. A.¹^ORCID,Lyakhova N. L.¹^ORCID,Alekseev V. G.¹^ORCID

Affiliation:

1. City Clinical Hospital n.a. S. P. Botkin

Abstract

The purpose of this work is to increase the alertness of doctors treating cancer patients due to the high risk of developing acute coronary syndrome (ACS) and understanding the pathogenetic mechanisms of the development of ACS. Antitumor therapy should be personalized and agreed upon by an interdisciplinary team with an assessment of the impact on the risk of developing ACS, especially in patients with high cardiovascular risk. Given the limited number of studies, principles for the management of cancer patients with ACS should be based on an assessment of ischemic and hemorrhagic risks.

Publisher

Alfmed LLC

Reference62 articles.

1. Navi B. B., Reiner A. S., Kamel H., Iadecola C., Okin P. M., Tagawa S. T., Panageas K. S., DeAngelis L. M. Arterial thromboembolic events preceding the diagnosis of cancer in old er persons. Blood. 2019; 133 (8): 781–789. https://doi.org/10.1182/blood2018–06–860874

2. Rohrmann S., Witassek F., Erne P., Rickli H., Radovanovic D. Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 639–645. https://doi.org/10.1177/2048872617729636

3. Wang F., Gulati R., Lennon R. J., Lewis B. R., Park J., Sandhu G. S., Wright R. S., Lerman A., Herrmann J. Cancer History Portends Worse Acute and Longterm Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute STSegment Elevation Myocardial Infarction. Mayo Clin Proc. 2016; 91 (12): 1680–1692. https://doi.org/10.1016/j.mayocp.2016.06.029

4. Gevaert S. A., Halvorsen S., Sinnaeve P. R., Sambola A., Gulati G., Lancellotti P., Van Der Meer P., Lyon A. R., Farmakis D., Lee G., Boriani G., Wechalekar A., Okines A., As teggiano R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A Consensus Document of the Acute Cardio Vascular Care (ACVC) association and the ESC council of CardioOncologyPart 1: Acute coronary syndromes and acute pericardial diseases. Eur Heart J Acute Cardiovasc Care. 2021; 10 (8): 947–959. PMID: 34453829. https://doi.org/10.1093/ehjacc/zuab056

5. Iannaccone M., D’Ascenzo F., Vadalà P., Wilton S. B., Noussan P., Colombo F., Rapo seiras Roubín S., Abu Assi E., GonzálezJuanatey J.R., Simao Henriques J. P., Saucedo J., Kikkert W. J., NuñezGil I., ArizaSole A., Song X. T., Alexopoulos D., Liebetrau C., Kawaji T., Moretti C., Garbo R., Huczek Z., Nie S. P., Fujii T, Correia L. C., Kawashiri M. A., García Acuña J. M., Southern D., Alfonso E., Terol B., Garay A., Zhang D., Chen Y., Xanthopou lou I., Osman N., Möllmann H., Shiomi H., Giordana F., Kowara M., Filipiak K., Wang X., Yan Y., Fan J. Y., Ikari Y., Nakahashi T., Sakata K., Gaita F., Yamagishi M., Kalpak O., Kedev S. Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 631–638. https://doi.org/10.1177/2048872617706501